 Tiziana Life Sciences PLC NASDAQ:TLSA, LON:TILS said it applied for UK government funding for its nasally administered antibody therapy under a scheme looking for take-home treatments for sufferers of Coronavirus COVID-19. Grants are being awarded to companies developing medicines that will prevent people with the illness from being hospitalised. 